Modified release formulations of a bupropion salt

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8932628
SERIAL NO

11762343

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VALEANT INTERNATIONAL (BARBADOS) SRLWEST INDIES

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Jackson, Graham County Kildare, IE 67 1302
Maes, Paul Toronto, CA 52 1315
Oberegger, Werner Mississauga, CA 34 853
Saleh, Mohammad Ashty Oakville, CA 18 631
Zhou, Fang Centreville, US 47 739

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 13, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00